Thursday May 25th 2017

Archive for September, 2010

To Bulgaria in November with hope

To Bulgaria in November with hope

It’s a trip to Bulgaria with lots of hope for Lorna Parton. The Port Colborne resident has her bags packed as she awaits a Nov. 18 flight to Sofia, Bulgaria, where she hopes a surgery performed by Dr. Paolo Zamboni will help correct a progressive form of multiple [Read More]

Man heading to Poland for MS treatment

Man heading to Poland for MS treatment

Hope shines in Renate Mackay’s eyes as she bubbles over with enthusiasm about the controversial liberation therapy, which many multiple sclerosis patients say is giving them their life back. Renate is praying the reports are true – and that the treatment will be [Read More]

Call in Ontario Legislature for new MS therapy

Call in Ontario Legislature for new MS therapy

A call for the province to provide a new treatment for multiple sclerosis made its way to the Ontario Legislature on Wednesday. Liberal MPP Aileen Carroll presented a petition signed by 8,000 people which demands the province recognize liberation therapy for those suffering [Read More]

 Page 1 of 32  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]